Christopher McGuigan

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horáková et al. · JAMA · 2019 · 511 citations · Full text

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

Anna He, B. Merkel, J William L Brown et al. · The Lancet Neurology · 2020 · 401 citations · Full text

Disease Progression, Neurological Disorder, Clinical Epidemiology +7

Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications

Paul C. Trippier, Christopher McGuigan · MedChemComm · 2010 · 330 citations

Immunology, Pharmacotherapy, Chemistry +18

Aryl Phosphoramidate Derivatives of d4T Have Improved Anti-HIV Efficacy in Tissue Culture and May Act by the Generation of a Novel Intracellular Metabolite

Christopher McGuigan, Dominique Cahard, Hendrika M. Sheeka et al. · Journal of Medicinal Chemistry · 1996 · 228 citations

Aryl Phosphoramidate Derivatives, Antiviral Drug, Phosphate Diester +19

Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT

Christopher McGuigan, Ranjith Pathirana, Jan Balzarini et al. · Journal of Medicinal Chemistry · 1993 · 214 citations